Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The HIV-1 Rev-responsive element IIB RNA (RRE IIB) is a highly structured RNA motif located within the env gene of the HIV-1 genome (Kjems et al., 1991, PNAS). It functions as the high-affinity docking site for the viral Rev protein, which is a prerequisite for the nuclear export of unspliced and singly spliced viral mRNA transcripts (Battiste et al., 1996, Science). This export process is vital for the synthesis of viral structural proteins and the packaging of the viral genome, making it a cornerstone of the HIV-1 replication cycle (Pollard and Malim, 1998, Annu Rev Microbiol). Disrupting the Rev-RRE IIB interaction leads to the nuclear retention and degradation of these transcripts, effectively preventing the assembly of new infectious particles. Consequently, RRE IIB is a prominent therapeutic target for small-molecule inhibitors, such as aminoglycosides and synthetic ligands, designed to block Rev binding (Zapp et al., 1993, Cell). Despite its potential, the primary challenge in targeting RRE IIB is ensuring selectivity to avoid interfering with essential host RNA-protein interactions, such as those involving the ribosome (Jayaraman et al., 2014, Bioorg Med Chem).
Inhibition of the Rev-RRE interaction, which prevents the nuclear export of unspliced and singly spliced viral mRNA, thereby blocking the production of viral structural proteins.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HIV-1 Rev-responsive element IIB RNA (RRE IIB).